Olink Bioscience said last week that it has teamed up with researchers at Uppsala University to found a subsidiary, Olink Genomics, to sell a multiplex amplification technology to select DNA for sequencing with second-generation technologies.
The early-stage Swedish company is joining a number of other firms, among them Roche NimbleGen, Agilent Technologies, and Febit, that are commercializing related DNA capture or selection technologies for sequencing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.